Cancer Biomarkers
Analytical Techniques for Discovery
Published on 2. March 2007
Book
Hardback
378 pages
978-0-471-74516-7 (ISBN)
Description
Tools, techniques, and progress in cancer biomarkers discovery
The completion of a number of gene sequencing projects, recent advances in genomic and proteomic technologies, and the availability of powerful bioinformatics tools have led to promising new avenues and approaches in the search for cancer biomarkers. This book provides a comprehensive overview of current methodologies and technologies. It discusses biomarker discovery as a whole, rather than focusing on one specific marker or cancer. With information on both existing and potential biomarkers, Cancer Biomarkers: Analytical Techniques for Discovery:
* Provides insights into the current technological platforms for biomarker discovery, including mass spectrometry combined with multidimensional chromatography, DIGE, and various chip technologies
* Includes a detailed discussion of protein networks and protein phosphorylation in cancer
* Details the use of imaging mass spectrometry, laser capture microdissection, serial analysis of gene expression, enzyme-linked immunosorbent assays, protein microarrays, antibody-based microarrays, and bioinformatics
* Covers the emerging role of surface-enhanced laser desorption ionization (SELDI) and various tagging and labeling strategies
* Discusses related regulatory and ethical issues
With a wealth of information that can be applied to a broad spectrum of biomarker research projects, this is a core reference for biomarker researchers, scientists working in proteomics and bioinformatics, pharmaceutical scientists, oncologists, biochemists, biologists, and chemists.
Reviews / Votes
Very well written and up-to-date. I recommend ... to anyone interested in learning about cancer research from the basic discovery to clinical stages. (The Yale Journal of Biology and Medicine, June 2007)More details
Product info
gebunden
Series
Edition
1. Auflage
Language
English
Place of publication
United States
Publishing group
John Wiley & Sons Inc
Target group
Professional and scholarly
Product notice
Laminated cover
Dimensions
Height: 239 mm
Width: 155 mm
Thickness: 25 mm
Weight
694 gr
ISBN-13
978-0-471-74516-7 (9780471745167)
Schweitzer Classification
Other editions
Additional editions
E-Book
08/2007
Wiley
€141.99
Available for download
Persons
MAHMOUD H. HAMDAN, PhD, FInstP, is the head of the Mass Spectrometry and Separation Technologies Laboratory at GlaxoSmithKline in Verona, Italy. He is a coauthor of Proteomics Today: Protein Assessment and Biomarkers Using Mass Spectrometry, 2D Electrophoresis, and Microarray Technology, also from Wiley.
Content
Preface.
Acknowledgments.
Introduction.
1 Overview.
1.1. Introduction.
1.2. Cancer Biomarkers.
1.3. Phases of Biomarkers Development.
1.4. New Approach to Biomarkers Discovery.
1.5. Initiatives Relevant to Biomarkers Discovery.
1.6. Concluding Remarks.
References.
2 Proteomic Platforms for Biomarkers Discovery.
2.1. Surface Enhanced Laser Desorption Ionization.
2.2. Bioinformatics in SELDI.
2.3. Some Representative SELDI Applications.
2.4. Two-dimensional Polyacrylamide Gel Electrophoresis.
2.5. Laser Capture Microdissection.
2.6. MS Analysis of Gel-separated Proteins.
2.7. Representative Applications of 2-DE for Biomarkers Discovery.
2.8. Protein Microarrays.
2.9. Multidimensional Liquid Chromatography Coupled to MS.
2.10. Chromatographic Separation.
2.11. Imaging Mass Spectrometry.
References.
3 Some Existing Cancer Biomarkers.
3.1. Introduction.
3.2. Historic Glimpse at PSA.
3.3. Prostate-specifi c Antigen.
3.4. PSA as a Screening Marker.
3.5. Improving the Specifi city of PSA.
3.6. Looking for Other Solutions.
3.7. Concluding Remarks.
3.8. Existing Biomarkers for Ovarian Cancer.
3.9. Osteopontin.
3.10. Combination of CA-125 with Other Potential Biomarkers.
3.11. Profi ling Proteins and Gene Expression in Ovarian Cancer.
3.12. General Observations.
References.
4 Potential Cancer Biomarkers.
4.1. Introduction.
4.2. Human Tissue Kallikreins.
4.3. Protein Family 14-3-3.
4.4. Heat Shock Proteins (HSPs).
4.5. Heat Shock Protein 27 (HSP27).
4.6. Heat Shock Protein 70 (HSP70).
4.7. General Remarks.
4.8. Calcium Binding Proteins.
4.9. DNA Methylation.
4.10. DNA Methylation in Cancer.
4.11. Inhibition of DNA Methylation.
4.12. Concluding Remarks.
References.
5 Protein Networks and Protein Phosphorylation in Cancer.
5.1. Introduction.
5.2. Protein Interaction Networks.
5.3. Computational Approaches.
5.4. Human Protein Intractome.
5.5. Relationship Between Gene Expression and Protein Interaction.
5.6. Gene Signatures in Cancer Prediction/Classifi cation.
5.7. Concluding Remarks.
5.8. Protein Phosphorylation.
5.9. Other Approaches.
5.10. The Phosphatidylinositol 3-Kinase-Akt Pathway (PI3K-Akt).
5.11. PIK3/Akt Alterations and Prognostic Biomarkers.
5.12. General Observations.
References.
6 Ethical Issues and Initiatives Relevant to Cancer Biomarkers.
6.1. Introduction.
6.2. Background.
6.3. Ethical Committees/Organizations.
6.4. Human Biobanks.
6.5. Large Population Screening.
6.6. Genetic Testing for Cancer Susceptibility.
6.7. Ethics in Phase I Oncology Trials.
6.8. Initiatives Relevant to Biomarkers Discovery.
6.9. Genomic Initiatives/Resources.
6.10. Achievements and Perspectives.
References.
Abbreviations.
Index.